COVID-19 reinfections in Mexico City: implications for public health

被引:1
作者
de Anda-Jauregui, Guillermo [1 ,2 ,3 ]
Gomez-Romero, Laura [1 ,4 ]
Canas, Sofia [1 ,5 ]
Campos-Romero, Abraham [6 ]
Alcantar-Fernandez, Jonathan [6 ]
Cedro-Tanda, Alberto [7 ]
机构
[1] Inst Nacl Med Genom, Mexico City, Mexico
[2] Consejo Nacl Humanidades Ciencias & Tecnol, Mexico City, Mexico
[3] Univ Nacl Autonoma Mexico, Ctr Ciencias Complejidad, Mexico City, Mexico
[4] Tecnol Monterrey, Escuela Med & Ciencias Salud, Mexico City, Mexico
[5] Inst Tecnol & Estudios Super Monterrey, Monterrey, Mexico
[6] Innovat & Res Dept, Culiacan, Mexico
[7] Inst Nacl Med Genom, Nucleo Innovac Med Precis B, Mexico City, Mexico
关键词
SARS-CoV-2; COVID-19; reinfections; Mexico City; epidemiological surveillance; vaccination strategies;
D O I
10.3389/fpubh.2023.1321283
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Since its appearance, COVID-19 has immensely impacted our society. Public health measures, from the initial lockdowns to vaccination campaigns, have mitigated the crisis. However, SARS-CoV-2's persistence and evolving variants continue to pose global threats, increasing the risk of reinfections. Despite vaccination progress, understanding reinfections remains crucial for informed public health responses. Methods: We collected available data on clinical and genomic information for SARS-CoV-2 samples from patients treated in Mexico City from 2020 epidemiological week 10 to 2023 epidemiological week 06 encompassing the whole public health emergency's period. To identify clinical data we utilized the SISVER (Respiratory Disease Epidemiological Surveillance System) database for SARS-CoV-2 patients who received medical attention in Mexico City. For genomic surveillance we analyzed genomic data previously uploaded to GISAID generated by Mexican institutions. We used these data sources to generate descriptors of case number, hospitalization, death and reinfection rates, and viral variant prevalence throughout the pandemic period. Findings: The fraction of reinfected individuals in the COVID-19 infected population steadily increased as the pandemic progressed in Mexico City. Most reinfections occurred during the fifth wave (40%). This wave was characterized by the coexistence of multiple variants exceeding 80% prevalence; whereas all other waves showed a unique characteristic dominant variant (prevalence >95%). Shifts in symptom patient care type and severity were observed, 2.53% transitioned from hospitalized to ambulatory care type during reinfection and 0.597% showed the opposite behavior; also 7.23% showed a reduction in severity of symptoms and 6.05% displayed an increase in severity. Unvaccinated individuals accounted for the highest percentage of reinfections (41.6%), followed by vaccinated individuals (31.9%). Most reinfections occurred after the fourth wave, dominated by the Omicron variant; and after the vaccination campaign was already underway. Interpretation: Our analysis suggests reduced infection severity in reinfections, evident through shifts in symptom severity and care patterns. Unvaccinated individuals accounted for most reinfections. While our study centers on Mexico City, its findings may hold implications for broader regions, contributing insights into reinfection dynamics.
引用
收藏
页数:12
相关论文
共 44 条
  • [1] Severity of SARS-CoV-2 Reinfections as Compared with Primary Infections
    Abu-Raddad, Laith J.
    Chemaitelly, Hiam
    Bertollini, Roberto
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (26) : 2487 - 2489
  • [2] Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 Among Previously Infected Healthcare Personnel and First Responders
    Akinbami, Lara J.
    Biggerstaff, Brad J.
    Chan, Philip A.
    McGibbon, Emily
    Pathela, Preeti
    Petersen, Lyle R.
    [J]. CLINICAL INFECTIOUS DISEASES, 2022, 75 (01) : E201 - E207
  • [3] Epidemiological assessment of SARS-CoV-2 reinfection
    Almadhi, Marwa
    Alsayyad, Adel Salman
    Conroy, Ronan
    Atkin, Stephen
    Al Awadhi, Abdulla
    Al-Tawfiq, Jaffar A.
    AlQahtani, Manaf
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2022, 123 : 9 - 16
  • [4] Protection of hybrid immunity against SARS-CoV-2 reinfection and severe COVID-19 during periods of Omicron variant predominance in Mexico
    Antonio Montes-Gonzalez, Jose
    Arturo Zaragoza-Jimenez, Christian
    Eduardo Antonio-Villa, Neftali
    Fermin-Martinez, Carlos A.
    Ramirez-Garcia, Daniel
    Vargas-Vazquez, Arsenio
    Idania Gutierrez-Vargas, Rosaura
    Garcia-Rodriguez, Gabriel
    Lopez-Gatell, Hugo
    Ivan Valdes-Ferrer, Sergio
    Yaxmehen Bello-Chavolla, Omar
    [J]. FRONTIERS IN PUBLIC HEALTH, 2023, 11
  • [5] Arora P, 2023, LANCET INFECT DIS, V23, P22, DOI 10.1016/S1473-3099(22)00733-2
  • [6] Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study
    Atti, Ana
    Insalata, Ferdinando
    Carr, Edward J.
    Otter, Ashley D.
    Castillo-Olivares, Javier
    Wu, Mary
    Harvey, Ruth
    Howell, Michael
    Chan, Andrew
    Lyall, Jonathan
    Temperton, Nigel
    Cantoni, Diego
    da Costa, Kelly
    Nadesalingam, Angalee
    Taylor-Kerr, Andrew
    Hettiarachchi, Nipunadi
    Tranquillini, Caio
    Hewson, Jacqueline
    Cole, Michelle J.
    Foulkes, Sarah
    Munro, Katie
    Monk, Edward J. M.
    Milligan, Iain D.
    Linley, Ezra
    Chand, Meera A.
    Brown, Colin S.
    Islam, Jasmin
    Semper, Amanda
    Charlett, Andre
    Heeney, Jonathan L.
    Beale, Rupert
    Zambon, Maria
    Hopkins, Susan
    Brooks, Tim
    Hall, Victoria
    [J]. JOURNAL OF INFECTION, 2022, 85 (05) : 545 - 556
  • [7] Assessing COVID-19 vaccination strategies in varied demographics using an individual-based model
    Ben-Zuk, Noam
    Daon, Yair
    Sasson, Amit
    Ben-Adi, Dror
    Huppert, Amit
    Nevo, Daniel
    Obolski, Uri
    [J]. FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [8] Acute and postacute sequelae associated with SARS-CoV-2 reinfection
    Bowe, Benjamin
    Xie, Yan
    Al-Aly, Ziyad
    [J]. NATURE MEDICINE, 2022, 28 (11) : 2398 - +
  • [9] BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
    Cao, Yunlong
    Yisimayi, Ayijiang
    Jian, Fanchong
    Song, Weiliang
    Xiao, Tianhe
    Wang, Lei
    Du, Shuo
    Wang, Jing
    Li, Qianqian
    Chen, Xiaosu
    Yu, Yuanling
    Wang, Peng
    Zhang, Zhiying
    Liu, Pulan
    An, Ran
    Hao, Xiaohua
    Wang, Yao
    Feng, Rui
    Sun, Haiyan
    Zhao, Lijuan
    Zhang, Wen
    Zhao, Dong
    Zheng, Jiang
    Yu, Lingling
    Li, Can
    Zhang, Na
    Wang, Rui
    Niu, Xiao
    Yang, Sijie
    Song, Xuetao
    Chai, Yangyang
    Hu, Ye
    Shi, Yansong
    Zheng, Linlin
    Li, Zhiqiang
    Gu, Qingqing
    Shao, Fei
    Huang, Weijin
    Jin, Ronghua
    Shen, Zhongyang
    Wang, Youchun
    Wang, Xiangxi
    Xiao, Junyu
    Xie, Xiaoliang Sunney
    [J]. NATURE, 2022, 608 (7923) : 593 - +
  • [10] CDC. Centers for Disease Control and Prevention, 2023, What is COVID-19 reinfection?